527 related articles for article (PubMed ID: 11251129)
1. What is the optimal medical management of ischemic heart failure?
Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
[TBL] [Abstract][Full Text] [Related]
2. [Ischemic heart failure].
Inoue K; Hori M
Nihon Rinsho; 2003 May; 61(5):862-6. PubMed ID: 12755016
[TBL] [Abstract][Full Text] [Related]
3. What is the optimal medical management of ischaemic heart failure?
Cleland JG; John J; Dhawan J; Clark A
Br Med Bull; 2001; 59():135-58. PubMed ID: 11756208
[TBL] [Abstract][Full Text] [Related]
4. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Ischemic versus non-ischemic heart failure: should the etiology be determined?
Follath F
Heart Fail Monit; 2001; 1(4):122-5. PubMed ID: 12634896
[TBL] [Abstract][Full Text] [Related]
7. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
9. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
Yokota Y
J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
[TBL] [Abstract][Full Text] [Related]
10. From left ventricular dysfunction to heart failure.
Cleland JG
Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
13. Community management of heart failure.
McKelvie RS
Can Fam Physician; 1998 Dec; 44():2689-92, 2695-8. PubMed ID: 9870122
[TBL] [Abstract][Full Text] [Related]
14. The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
Liu P; Arnold M; Belenkie I; Howlett J; Huckell V; Ignazewski A; LeBlanc MH; McKelvie R; Niznick J; Parker JD; Rao V; Ross H; Roy D; Smith S; Sussex B; Teo K; Tsuyuki R; White M; Beanlands D; Bernstein V; Davies R; Issac D; Johnstone D; Lee H; Moe G; Newton G; Pflugfelder P; Roth S; Rouleau J; Yusuf S;
Can J Cardiol; 2001 Dec; 17 Suppl E():5E-25E. PubMed ID: 11773943
[No Abstract] [Full Text] [Related]
15. A review of heart failure treatment.
Guyatt GH; Devereaux PJ
Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
[TBL] [Abstract][Full Text] [Related]
16. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of cardiac insufficiency with systolic dysfunction].
Follath F
Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
19. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
20. beta-Blocker therapy in heart failure.
Doughty RN
Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
